Cannabis for the Prophylactic Treatment of Migraine
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of cannabis for the treatment of chronic
migraine headaches. Study subjects will be randomized to one of three groups: lower dose CBD,
higher dose CBD or placebo.